The Indiana University Melvin and Bren Simon Comprehensive Cancer Center was awarded a prestigious grant to train the next generation of cancer drug discovery and development researchers.
Known as a T32 grant, the five-year, $794,000 National Cancer Institute award will establish the Pediatric and Adult Translational Cancer Drug Discovery and Development Training Program . The award supports three graduate fellows annually, with the cancer center adding to the grant to support an additional two students.
Mark R. Kelley, PhD, the Betty and Earl Herr Professor of Pediatric Oncology Research at IU School of Medicine and the associate director of basic science research at the cancer center The PACT-D3 will allow graduate fellows to have a cancer center mentor who is conducting research in drug discovery and development while learning about potential career paths in academic, biotech and pharma settings. Fellows will be paired with an investigator whose lab focuses on pediatric cancers, adult cancers or overlapping efforts.
Related StoriesFellows will also have access to learning opportunities through the Cancer Drug Discovery and Development Accelerator , which was launched by the cancer center in 2019. This initiative accelerates the journey from research to the clinic by fostering collaborations between university researchers, experienced pharmaceutical industry veterans, technology cores, and external research organizations.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
BGI Genomics and Colombian National Cancer Institute Collaborate to enhance cancer detection and preventionitemprop=description content=On October 2, 2023, BGI Genomics signed a Memorandum of Understanding (MoU) with the Colombian National Cancer Institute (INC or Instituto Nacional de Cancerologia).
Consulte Mais informação »
Copycat nutrient leaves pancreatic tumors starving, may inform cancer treatmentA study led by scientists at Sanford Burnham Prebys suggests an entirely new approach to treat pancreatic cancer. The research shows that feeding tumors a copycat of an important nutrient starves them of the fuel they need to survive and grow. The method, described in the journal Nature Cancer, has been used in early clinical trials for lung cancer. However, the unique properties of pancreatic cancer may make the strategy an even stronger candidate in the pancreas.
Consulte Mais informação »
New discovery sheds light on how BRCA1 mutations cause cancer in womenitemprop=description content=Three decades after discoveries linking mutations in the BRCA1 gene to breast and ovarian cancer susceptibility, research led by Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has pinpointed the molecular mechanism by which a large portion of these mutations cause cancers in women.
Consulte Mais informação »
UH's SUSTAIN Center makes lasting impact in fight against HIV epidemic in Southern U.S.itemprop=description content=The SUSTAIN Wellbeing COMPASS Coordinating Center of the University of Houston Graduate College of Social Work has made a lasting impact in the fight against the HIV epidemic in the Southern U.S. over the past five years, particularly for Black and Latinx-led organizations.
Consulte Mais informação »
Sino Biological Announces the Opening of Its New US-Based Center for Bioprocessingitemprop=description content=Sino Biological, Inc. is pleased to announce the formal opening of its new Center for Bioprocessing (C4B) in Houston, Texas USA at Levit Green, adjacent to the world-renowned Texas Medical Center.
Consulte Mais informação »